{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Hematologist","title":"Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/66e16bdf\"></iframe>","width":"100%","height":180,"duration":1313,"description":"In this episode, Contributing Editor Brian Hill, MD, PhD, speaks with Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center in New York. Their conversation focuses on Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia.","thumbnail_url":"https://img.transistorcdn.com/UV_KyPwV-T-4orH0ygSBcFOjHh1uy0PhPRgI8Wyax7g/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzIxNjc1LzE2MzE1/NTM2MTEtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}